Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 613-953-8 | CAS number: 66603-10-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Version / remarks:
- 13 Apr 2004
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guidance Document No. 28 for the conduct of skin absorption studies, March 2004
- Version / remarks:
- March 2004
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Cyclohexylhydroxydiazene 1-oxide, potassium salt
- EC Number:
- 613-953-8
- Cas Number:
- 66603-10-9
- Molecular formula:
- C6H11KN2O2
- IUPAC Name:
- Cyclohexylhydroxydiazene 1-oxide, potassium salt
- Test material form:
- liquid
- Details on test material:
- Xyligen 30F is a 30% aqueous solution of K-HDO.
Constituent 1
- Specific details on test material used for the study:
- NON-LABELED TEST SUBSTANCE:
Name of test substance: Xyligen 30 F
Test substance No.: 01/0069-7
Batch Identification: 44827924
CAS No.: 66603-10-9
Purity: Aqueous formulation; content of active ingredient K-HDO: 31.2%
Homogeneity: The test substance appeared to be homogeneous by visual inspection.
Storage stability: The stability of the test substance under storage conditions over the test period was guaranteed by the sponsor.
RADIOLABELED TEST SUBSTANCE:
Name of test substance: 14C-Reg. No. 5214771 (N-Cyclohexyldiazeniumdioxy-potassium)
Test substance No.: 05/0892-1
Batch Identification: 266-2001
Radiochemical purity: 98.9% (see Certificate of Analysis in Appendix 9.1).
Homogeneity: The homogeneity of the test substance was confirmed by analysis.
ADDITIONAL TEST SUBSTANCE INFORMATION:
IUPAC name: N-Cyclohexyldiazeniumdioxy-potassium
Label: K-HDO-U-C14
Specific activity: 3.66 MBq/mg a.i. - Radiolabelling:
- yes
Test animals
- Species:
- other: not applicable, an in vitro test method was used
- Strain:
- not specified
- Remarks:
- not applicable, an in vitro test method was used
- Details on test animals or test system and environmental conditions:
- Not applicable, an in vitro test method was used.
Administration / exposure
- Type of coverage:
- other: not applicable, an in vitro test method was used
- Vehicle:
- other:
- Remarks:
- not applicable, an in vitro test method was used
- Doses:
- see tables below
- No. of animals per group:
- not applicable
- Details on in vitro test system (if applicable):
- SKIN PREPARATION
- Source of skin: human donor
- Type of skin: Skin from abdomen
- Preparative technique: Split thickness skin preparations
- Supplier: Dermatomed human skin preparations with a thickness of 409 – 579 μm were supplied frozen by BIOPREDIC International, Rennes, France. On receipt they were vacuum-wrapped, labeled appropriately and stored frozen at –20°C until use.
- Thickness of skin (in mm): 409 – 579 μm
- Membrane integrity check: Before connecting the diffusion cell, equipped with skin preparation, to the experimental setup, the integrity of the skin preparation was determined by measuring its electrical resistance with a LCR bridge (LCR 400, Thurlby Thandar Instruments, England). For this purpose, about 0.8 mL physiological saline solution was pipetted onto the skin preparation and a stainless steel electrode (donor electrode diameter 2.05 mm) was suspended into the fluid column to a depth of about 0.5 cm. A further electrode (receptor electrode diameter about 0.95 mm) was introduced into the receptor compartment via the inlet of the Franz cell as far as possible. After the two electrodes were connected to the LCR 400 measuring bridge, the measured resistance was directly read on the display of the device. Measured values above 1 kOhm were expected for intact skin preparations (results are available in the raw data). In addition, skin preparation integrity was checked immediately before the application of the test substance preparation and immediately before the sampling procedures for balancing by visual inspection.
In the case of measured low resistance values, skin preparations were used unless the visual check revealed any damage. Further evaluation was based on the plausibility of results obtained for an individual skin preparation when compared to those obtained for the entire dose group. The following findings were reasons for not using a skin preparation in the study or rejecting results from calculation of the mean penetration parameters:
* A skin preparation showed low resistance and physical damage or leakage of receptor medium to the surface.
* A skin preparation displayed clearly aberrant test substance recovery rates (according to the guidelines of OECD a total recovery per membrane of 100 ± 10% is considered to be acceptable).
* A membrane displayed clearly aberrant penetration kinetics.
- Storage conditions: Skin preparations were stored for a maximum of 12 months at -20°C. Skin preparations were used no longer than the day after thawing in a refrigerator. Multiple freezing was omitted.
- Justification of species, anatomical site and preparative technique: Split thickness skin preparations were used to obtain as standardized test conditions as possible. This test system was used to determine the skin absorption of test substances in numerous investigations and represent a substantially validated model (see OECD Guidance Document No. 28). The preparations were supplied already dermatomized by the source stated above.
PRINCIPLES OF ASSAY
- Diffusion cell: Modified Franz cell consisting of an upper donor compartment and a wide opening at the top and a lower receptor compartment
- Receptor fluid: tap water
- Solubility od test substance in receptor fluid: The maximum solubility of the test substance in water is 542 g/L. Taking into account the maximum dose of active ingredient and the total volume of receptor fluid used including sampling, no rate limiting effects on the diffusion process by saturation of the receptor fluid is expected.
- Static system: The diffusion cells were operated in the static mode.
- Test temperature: 32 ± 1°C
- Occlusion: The donor compartment was covered with a sheet of Fixomull® Stretch (semiocclusive adhesive fleece).
- Other: The stability of the test substance in the test substance preparation over the test period was verified by analysis. The concentration and the homogeneous distribution of the test substance in the test substance preparation were confirmed by analysis.
Results and discussion
- Absorption in different matrices:
- See table below.
- Total recovery:
- See table below.
Any other information on results incl. tables
Mean recovery rates from the different compartments of the diffusion cell
Nominal Dose of Test Substance [μg] |
3120 |
|
Mean applied Dose of Test Substance [μg] |
3194 |
|
|
Dose of Test Substance Found [μg] |
% of Applied Dose |
Non-absorbed Dose |
|
|
Tape strips |
69.8 |
2.18 |
Membrane Washing |
2566.5 |
80.37 |
Sum |
2636.3 |
82.55 |
Skin preparation |
92.9 |
2.90 |
Absorbed Dose |
|
|
Sum Receptor Samples 0 - 24 h Including Wash Out |
93.4 |
2.93 |
Receptor Fluid |
358.9 |
11.22 |
Receptor Chamber Washing |
7.0 |
0.22 |
Sum |
459.3 |
14.37 |
Total |
3188.5 |
|
Total Recovery |
|
99.83 |
The mean total recovery measured in the diffusion cells fulfilled the OECD quality criteria.
The individual values ranged between 98 and 101%. The major amount of supplied test substance was recovered from the skin membrane washings and tape strips (83%). The individual values ranged between 72.5 and 86.9%. About 3% of the test substance was associated with the skin membrane. The individual values ranged between 1.3 and 4.8%. About 14% were recovered from the receptor fluid and receptor compartment, which is considered to represent the absorbed dose. The individual values ranged between 9.2 and 21.6%.
Nominal Dose of Test Preparation [mg/cm²] |
10 |
|
Nominal Dose of Test Substance [µg/cm²] |
3120 |
|
Applied Dose of Test Substance [µg/cm²] |
3194 |
|
Sample Time [h] |
Mean Cumulative Absorption of the Test Substance [µg/cm²] |
Percentage Absorption |
0.5 |
1.55 |
0.05 |
1 |
4.87 |
0.15 |
2 |
13.24 |
0.42 |
4 |
38.02 |
1.19 |
6 |
75.45 |
2.37 |
10 |
159.34 |
5.00 |
24 |
435.49 |
13.62 |
|
|
|
Kp [*10-5cm/h] |
8.81 |
|
Absorption Rate [µg / (cm²*h)] |
27.98 |
|
Lag Time [ h ] |
4.13 |
|
Applicant's summary and conclusion
- Conclusions:
- In conclusion, the total recovery rates of the test substance show the validity of the experimental results. According to the categorization schemes suggested by Marzulli et al. 1969 and Barber et al. 1995 the permeability constant (Kp) shows a moderate penetration of 14C-Reg. No. 5214771 (N-Cyclohexyldiazeniumdioxy-potassium) through human skin preparations under the test conditions used.
- Executive summary:
The dermal penetration of the active ingredient through human skin in vitro was examined after application of a formulation concentrate to dermatomized skin preparations mounted on Franz-type diffusion cells.
The target dose of about 10 mg or μL/cm² corresponding to about 3120 μg/cm² of the test substance formulation was achieved well.
The total recovery rates range between 98.2 and 101.3% of the applied dose, which is fully in compliance with the quality criteria of the OECD Guideline.
The major amount of the test substance was recovered from the skin membrane washings and tape strips. This non-absorbed dose was about 82.6%.
The mean relative amount of test substance associated with the skin preparation was 2.9%. The relative mean absorbed dose, i.e. the amount of test substance found in the samples of the receptor fluid and derived from the receptor compartment washes in relation to the applied dose, was 14.4%. This indicates some diffusion occurs across the skin membranes.
The permeability constant was calculated from the absorption rate (about 28 μg/(cm²*h) and the concentration of the applied test substance preparation to be 8.8*10-5 cm/h. The region of the steepest slope of individual absorption-time curves was used for linear regression analysis. Thus the value represents the maximum penetration constant. According to the categorization schemes of Marzulli et al. 1969 and Barber et al. 1995 the permeability constant (Kp) shows a moderate penetration of the test substance through human skin under the test conditions used.
The mean absorption lag time was calculated to be about 4 hours. The presence of a lag time of absorption underlines the functional diffusion barrier of the skin against the tested substance preparation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.